The 5th Annual Mobile in Clinical Trials Event Presents Agenda for September 24, 2018
NEW YORK (PRWEB) July 26, 2018 -- The Conference Forum has confirmed the agenda for the 5th Annual Mobile in Clinical Trials event, which will take place on September 24, 2018 at the Marriott Copley Place in Boston, MA.
Daniel Karlin, MD, Head of Experimental Medicine, Informatics, and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, returns as program chair to lead the discussion on how and when to implement mobile/digital technology in clinical trials and the potential benefits to be gained.
“Now in its fifth year, the Mobile program brings together speakers from key contributors to the development of digital technology to connect and empower patients in clinical trials,” says Conference Producer, Jennifer Moran. “Scheduled immediately before the 8th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference and at the same venue, this full-day event provides an ideal opportunity to discover more about the value of using digital tools in drug development.”
The morning features industry case studies from Bayer, Merck, Novartis, Eli Lilly, and Pfizer who will present learnings from their implementation of digital strategies. This includes: Bayer's perspective on the good the bad and the ugly of mobile health; Merck’s latest progress report on the implementation of their AI and digital R&D strategy; how Novartis utilize the ResearchKit platform; Eli Lilly's recommendations for launching multiple devices in a trial; case study learnings from Philips; Pfizer's lessons learned from a regulatory interaction; and new technologies in live five-minute demonstrations.
The afternoon sessions cover a range of topics to equip the audience with strategies and innovative ideas to move the needle forward in an increasingly digital landscape. From an interactive group activity focused on data sharing to sessions on aligning the promise of technology with the patient voice and pre-competitive collaborations to accelerate the advancement of mobile/digital tools, these conversations provide a space for leaders of the industry to have open and honest discussions about the future of digital in clinical trials.
Mobile in Clinical Trials concludes with strategic thoughts for a roadmap to organizational and digital restructuring to scale mobile clinical trials and moving beyond the accelerometer, what's next for mobile clinical trials.
To find out more about Mobile in Clinical Trials, click here for full event details.
About the Conference Forum
The Conference Forum is a research firm that develops specialized events for professionals in the life science and healthcare industries. The company currently offers conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum’s mission is to create the best content, facilitate the exchange ideas and provide quality networking to help move therapeutics to patients faster. Click here to learn more about The Conference Forum.
Allyson Adams, The Conference Forum LLC, http://theconferenceforum.org/, +1 (646) 290-6797, [email protected]
Share this article